Global Antibody Services Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 265525
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Services
Buy @ $3500

The Antibody Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Antibody Services market size is estimated to be worth US$ 2065.7 million in 2021 and is forecast to a readjusted size of USD 3775.2 million by 2028 with a CAGR of 9.0% during review period. BioScience Companies accounting for % of the Antibody Services global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Antibody Services include ThermoFisher, GenScript, Abcam, MBS, and ROCKLAND, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Antibody Services market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Monoclonal

Polyclonal

Others

Market segment by Application, can be divided into

BioScience Companies

BioScience Research Institutions

Hospitals

Other

Market segment by players, this report covers

ThermoFisher

GenScript

Abcam

MBS

ROCKLAND

ProSci

Anaspec

Bio-Rad

Covance

Capra Science

Innovagen

APS

Randox

GL Biochem

Abgent

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Antibody Services product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Antibody Services, with revenue, gross margin and global market share of Antibody Services from 2019 to 2022.

Chapter 3, the Antibody Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Antibody Services market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Antibody Services research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Antibody Services

1.2 Classification of Antibody Services by Type

1.2.1 Overview: Global Antibody Services Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Antibody Services Revenue Market Share by Type in 2021

1.2.3 Monoclonal

1.2.4 Polyclonal

1.2.5 Others

1.3 Global Antibody Services Market by Application

1.3.1 Overview: Global Antibody Services Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 BioScience Companies

1.3.3 BioScience Research Institutions

1.3.4 Hospitals

1.3.5 Other

1.4 Global Antibody Services Market Size & Forecast

1.5 Global Antibody Services Market Size and Forecast by Region

1.5.1 Global Antibody Services Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Antibody Services Market Size by Region, (2017-2022)

1.5.3 North America Antibody Services Market Size and Prospect (2017-2028)

1.5.4 Europe Antibody Services Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Antibody Services Market Size and Prospect (2017-2028)

1.5.6 South America Antibody Services Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Antibody Services Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Antibody Services Market Drivers

1.6.2 Antibody Services Market Restraints

1.6.3 Antibody Services Trends Analysis

2 Company Profiles

2.1 ThermoFisher

2.1.1 ThermoFisher Details

2.1.2 ThermoFisher Major Business

2.1.3 ThermoFisher Antibody Services Product and Solutions

2.1.4 ThermoFisher Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 ThermoFisher Recent Developments and Future Plans

2.2 GenScript

2.2.1 GenScript Details

2.2.2 GenScript Major Business

2.2.3 GenScript Antibody Services Product and Solutions

2.2.4 GenScript Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 GenScript Recent Developments and Future Plans

2.3 Abcam

2.3.1 Abcam Details

2.3.2 Abcam Major Business

2.3.3 Abcam Antibody Services Product and Solutions

2.3.4 Abcam Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Abcam Recent Developments and Future Plans

2.4 MBS

2.4.1 MBS Details

2.4.2 MBS Major Business

2.4.3 MBS Antibody Services Product and Solutions

2.4.4 MBS Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 MBS Recent Developments and Future Plans

2.5 ROCKLAND

2.5.1 ROCKLAND Details

2.5.2 ROCKLAND Major Business

2.5.3 ROCKLAND Antibody Services Product and Solutions

2.5.4 ROCKLAND Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 ROCKLAND Recent Developments and Future Plans

2.6 ProSci

2.6.1 ProSci Details

2.6.2 ProSci Major Business

2.6.3 ProSci Antibody Services Product and Solutions

2.6.4 ProSci Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 ProSci Recent Developments and Future Plans

2.7 Anaspec

2.7.1 Anaspec Details

2.7.2 Anaspec Major Business

2.7.3 Anaspec Antibody Services Product and Solutions

2.7.4 Anaspec Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Anaspec Recent Developments and Future Plans

2.8 Bio-Rad

2.8.1 Bio-Rad Details

2.8.2 Bio-Rad Major Business

2.8.3 Bio-Rad Antibody Services Product and Solutions

2.8.4 Bio-Rad Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Bio-Rad Recent Developments and Future Plans

2.9 Covance

2.9.1 Covance Details

2.9.2 Covance Major Business

2.9.3 Covance Antibody Services Product and Solutions

2.9.4 Covance Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Covance Recent Developments and Future Plans

2.10 Capra Science

2.10.1 Capra Science Details

2.10.2 Capra Science Major Business

2.10.3 Capra Science Antibody Services Product and Solutions

2.10.4 Capra Science Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Capra Science Recent Developments and Future Plans

2.11 Innovagen

2.11.1 Innovagen Details

2.11.2 Innovagen Major Business

2.11.3 Innovagen Antibody Services Product and Solutions

2.11.4 Innovagen Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Innovagen Recent Developments and Future Plans

2.12 APS

2.12.1 APS Details

2.12.2 APS Major Business

2.12.3 APS Antibody Services Product and Solutions

2.12.4 APS Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 APS Recent Developments and Future Plans

2.13 Randox

2.13.1 Randox Details

2.13.2 Randox Major Business

2.13.3 Randox Antibody Services Product and Solutions

2.13.4 Randox Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Randox Recent Developments and Future Plans

2.14 GL Biochem

2.14.1 GL Biochem Details

2.14.2 GL Biochem Major Business

2.14.3 GL Biochem Antibody Services Product and Solutions

2.14.4 GL Biochem Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 GL Biochem Recent Developments and Future Plans

2.15 Abgent

2.15.1 Abgent Details

2.15.2 Abgent Major Business

2.15.3 Abgent Antibody Services Product and Solutions

2.15.4 Abgent Antibody Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Abgent Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Antibody Services Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Antibody Services Players Market Share in 2021

3.2.2 Top 10 Antibody Services Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Antibody Services Players Head Office, Products and Services Provided

3.4 Antibody Services Mergers & Acquisitions

3.5 Antibody Services New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Antibody Services Revenue and Market Share by Type (2017-2022)

4.2 Global Antibody Services Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Antibody Services Revenue Market Share by Application (2017-2022)

5.2 Global Antibody Services Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Antibody Services Revenue by Type (2017-2028)

6.2 North America Antibody Services Revenue by Application (2017-2028)

6.3 North America Antibody Services Market Size by Country

6.3.1 North America Antibody Services Revenue by Country (2017-2028)

6.3.2 United States Antibody Services Market Size and Forecast (2017-2028)

6.3.3 Canada Antibody Services Market Size and Forecast (2017-2028)

6.3.4 Mexico Antibody Services Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Antibody Services Revenue by Type (2017-2028)

7.2 Europe Antibody Services Revenue by Application (2017-2028)

7.3 Europe Antibody Services Market Size by Country

7.3.1 Europe Antibody Services Revenue by Country (2017-2028)

7.3.2 Germany Antibody Services Market Size and Forecast (2017-2028)

7.3.3 France Antibody Services Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Antibody Services Market Size and Forecast (2017-2028)

7.3.5 Russia Antibody Services Market Size and Forecast (2017-2028)

7.3.6 Italy Antibody Services Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Antibody Services Revenue by Type (2017-2028)

8.2 Asia-Pacific Antibody Services Revenue by Application (2017-2028)

8.3 Asia-Pacific Antibody Services Market Size by Region

8.3.1 Asia-Pacific Antibody Services Revenue by Region (2017-2028)

8.3.2 China Antibody Services Market Size and Forecast (2017-2028)

8.3.3 Japan Antibody Services Market Size and Forecast (2017-2028)

8.3.4 South Korea Antibody Services Market Size and Forecast (2017-2028)

8.3.5 India Antibody Services Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Antibody Services Market Size and Forecast (2017-2028)

8.3.7 Australia Antibody Services Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Antibody Services Revenue by Type (2017-2028)

9.2 South America Antibody Services Revenue by Application (2017-2028)

9.3 South America Antibody Services Market Size by Country

9.3.1 South America Antibody Services Revenue by Country (2017-2028)

9.3.2 Brazil Antibody Services Market Size and Forecast (2017-2028)

9.3.3 Argentina Antibody Services Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Antibody Services Revenue by Type (2017-2028)

10.2 Middle East & Africa Antibody Services Revenue by Application (2017-2028)

10.3 Middle East & Africa Antibody Services Market Size by Country

10.3.1 Middle East & Africa Antibody Services Revenue by Country (2017-2028)

10.3.2 Turkey Antibody Services Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Antibody Services Market Size and Forecast (2017-2028)

10.3.4 UAE Antibody Services Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Antibody Services Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Antibody Services Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Antibody Services Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Antibody Services Revenue (USD Million) by Region (2017-2022)

Table 5. Global Antibody Services Revenue Market Share by Region (2023-2028)

Table 6. ThermoFisher Corporate Information, Head Office, and Major Competitors

Table 7. ThermoFisher Major Business

Table 8. ThermoFisher Antibody Services Product and Solutions

Table 9. ThermoFisher Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. GenScript Corporate Information, Head Office, and Major Competitors

Table 11. GenScript Major Business

Table 12. GenScript Antibody Services Product and Solutions

Table 13. GenScript Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Abcam Corporate Information, Head Office, and Major Competitors

Table 15. Abcam Major Business

Table 16. Abcam Antibody Services Product and Solutions

Table 17. Abcam Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. MBS Corporate Information, Head Office, and Major Competitors

Table 19. MBS Major Business

Table 20. MBS Antibody Services Product and Solutions

Table 21. MBS Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. ROCKLAND Corporate Information, Head Office, and Major Competitors

Table 23. ROCKLAND Major Business

Table 24. ROCKLAND Antibody Services Product and Solutions

Table 25. ROCKLAND Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. ProSci Corporate Information, Head Office, and Major Competitors

Table 27. ProSci Major Business

Table 28. ProSci Antibody Services Product and Solutions

Table 29. ProSci Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Anaspec Corporate Information, Head Office, and Major Competitors

Table 31. Anaspec Major Business

Table 32. Anaspec Antibody Services Product and Solutions

Table 33. Anaspec Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Bio-Rad Corporate Information, Head Office, and Major Competitors

Table 35. Bio-Rad Major Business

Table 36. Bio-Rad Antibody Services Product and Solutions

Table 37. Bio-Rad Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Covance Corporate Information, Head Office, and Major Competitors

Table 39. Covance Major Business

Table 40. Covance Antibody Services Product and Solutions

Table 41. Covance Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Capra Science Corporate Information, Head Office, and Major Competitors

Table 43. Capra Science Major Business

Table 44. Capra Science Antibody Services Product and Solutions

Table 45. Capra Science Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Innovagen Corporate Information, Head Office, and Major Competitors

Table 47. Innovagen Major Business

Table 48. Innovagen Antibody Services Product and Solutions

Table 49. Innovagen Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. APS Corporate Information, Head Office, and Major Competitors

Table 51. APS Major Business

Table 52. APS Antibody Services Product and Solutions

Table 53. APS Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Randox Corporate Information, Head Office, and Major Competitors

Table 55. Randox Major Business

Table 56. Randox Antibody Services Product and Solutions

Table 57. Randox Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. GL Biochem Corporate Information, Head Office, and Major Competitors

Table 59. GL Biochem Major Business

Table 60. GL Biochem Antibody Services Product and Solutions

Table 61. GL Biochem Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Abgent Corporate Information, Head Office, and Major Competitors

Table 63. Abgent Major Business

Table 64. Abgent Antibody Services Product and Solutions

Table 65. Abgent Antibody Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Antibody Services Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Antibody Services Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Antibody Services by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Antibody Services Players Head Office, Products and Services Provided

Table 70. Antibody Services Mergers & Acquisitions in the Past Five Years

Table 71. Antibody Services New Entrants and Expansion Plans

Table 72. Global Antibody Services Revenue (USD Million) by Type (2017-2022)

Table 73. Global Antibody Services Revenue Share by Type (2017-2022)

Table 74. Global Antibody Services Revenue Forecast by Type (2023-2028)

Table 75. Global Antibody Services Revenue by Application (2017-2022)

Table 76. Global Antibody Services Revenue Forecast by Application (2023-2028)

Table 77. North America Antibody Services Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Antibody Services Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Antibody Services Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Antibody Services Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Antibody Services Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Antibody Services Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Antibody Services Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Antibody Services Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Antibody Services Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Antibody Services Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Antibody Services Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Antibody Services Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Antibody Services Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Antibody Services Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Antibody Services Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Antibody Services Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Antibody Services Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Antibody Services Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Antibody Services Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Antibody Services Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Antibody Services Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Antibody Services Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Antibody Services Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Antibody Services Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Antibody Services Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Antibody Services Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Antibody Services Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Antibody Services Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Antibody Services Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Antibody Services Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Antibody Services Picture

Figure 2. Global Antibody Services Revenue Market Share by Type in 2021

Figure 3. Monoclonal

Figure 4. Polyclonal

Figure 5. Others

Figure 6. Antibody Services Revenue Market Share by Application in 2021

Figure 7. BioScience Companies Picture

Figure 8. BioScience Research Institutions Picture

Figure 9. Hospitals Picture

Figure 10. Other Picture

Figure 11. Global Antibody Services Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Antibody Services Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Antibody Services Revenue Market Share by Region (2017-2028)

Figure 14. Global Antibody Services Revenue Market Share by Region in 2021

Figure 15. North America Antibody Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Antibody Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Antibody Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Antibody Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Antibody Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Antibody Services Market Drivers

Figure 21. Antibody Services Market Restraints

Figure 22. Antibody Services Market Trends

Figure 23. ThermoFisher Recent Developments and Future Plans

Figure 24. GenScript Recent Developments and Future Plans

Figure 25. Abcam Recent Developments and Future Plans

Figure 26. MBS Recent Developments and Future Plans

Figure 27. ROCKLAND Recent Developments and Future Plans

Figure 28. ProSci Recent Developments and Future Plans

Figure 29. Anaspec Recent Developments and Future Plans

Figure 30. Bio-Rad Recent Developments and Future Plans

Figure 31. Covance Recent Developments and Future Plans

Figure 32. Capra Science Recent Developments and Future Plans

Figure 33. Innovagen Recent Developments and Future Plans

Figure 34. APS Recent Developments and Future Plans

Figure 35. Randox Recent Developments and Future Plans

Figure 36. GL Biochem Recent Developments and Future Plans

Figure 37. Abgent Recent Developments and Future Plans

Figure 38. Global Antibody Services Revenue Share by Players in 2021

Figure 39. Antibody Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 40. Global Top 3 Players Antibody Services Revenue Market Share in 2021

Figure 41. Global Top 10 Players Antibody Services Revenue Market Share in 2021

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 43. Global Antibody Services Revenue Share by Type in 2021

Figure 44. Global Antibody Services Market Share Forecast by Type (2023-2028)

Figure 45. Global Antibody Services Revenue Share by Application in 2021

Figure 46. Global Antibody Services Market Share Forecast by Application (2023-2028)

Figure 47. North America Antibody Services Sales Market Share by Type (2017-2028)

Figure 48. North America Antibody Services Sales Market Share by Application (2017-2028)

Figure 49. North America Antibody Services Revenue Market Share by Country (2017-2028)

Figure 50. United States Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Canada Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Mexico Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Europe Antibody Services Sales Market Share by Type (2017-2028)

Figure 54. Europe Antibody Services Sales Market Share by Application (2017-2028)

Figure 55. Europe Antibody Services Revenue Market Share by Country (2017-2028)

Figure 56. Germany Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. France Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. United Kingdom Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Russia Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Italy Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Asia-Pacific Antibody Services Sales Market Share by Type (2017-2028)

Figure 62. Asia-Pacific Antibody Services Sales Market Share by Application (2017-2028)

Figure 63. Asia-Pacific Antibody Services Revenue Market Share by Region (2017-2028)

Figure 64. China Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Japan Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South Korea Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. India Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Southeast Asia Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Australia Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. South America Antibody Services Sales Market Share by Type (2017-2028)

Figure 71. South America Antibody Services Sales Market Share by Application (2017-2028)

Figure 72. South America Antibody Services Revenue Market Share by Country (2017-2028)

Figure 73. Brazil Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Argentina Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Middle East and Africa Antibody Services Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa Antibody Services Sales Market Share by Application (2017-2028)

Figure 77. Middle East and Africa Antibody Services Revenue Market Share by Country (2017-2028)

Figure 78. Turkey Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. UAE Antibody Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source